Protein

Blocking new protein helps immune system to fight cancer

28 August 2019 | By Rachael Harper (Drug Target Review)

A protein discovery could lead to a new and highly potent immune-therapeutic drug for the eradication of cancers using natural killer cells.

Telomere damage in cells is caused by runaway mitochondria

27 August 2019 | By Rachael Harper (Drug Target Review)

Using new technology researchers have shown that sick mitochondria pollute the cells they are supposed to be supplying with power.

Study uncovers key processes behind MYC cancer gene

26 August 2019 | By Victoria Rees (Drug Target Review)

Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.

Succinate in cystic fibrosis lungs feeds deadly bacteria

23 August 2019 | By Rachael Harper (Drug Target Review)

Targeting a deadly bacteria's use of succinate in the lungs could control infection and improve the health of people with cystic fibrosis.

Gene linked to rare disorder also regulates key enzyme in Alzheimer’s

22 August 2019 | By Rachael Harper (Drug Target Review)

A gene associated with a rare balance disorder also regulates the behaviour of an enzyme that increases the risk for Alzheimer's disease.

New drug target for glioblastoma identified by study

21 August 2019 | By Rachael Harper (Drug Target Review)

A new drug target for treating glioblastoma has been identified from a cellular pathway found to contribute to the spread of glioma stem cells.

Tosoh Bioscience

Genes responsible for gender differences in tumours identified

19 August 2019 | By Rachael Harper (Drug Target Review)

A new study has identified possible regulators that determine differences in cancer tumours between genders.

Electrical channels in retina could play role in degenerative diseases

16 August 2019 | By Victoria Rees (Drug Target Review)

Researchers have discovered electrical channels important in sensory cell renewal which could be studied further to develop therapies for retinal diseases.

Genes linked to Alzheimer’s risk have been identified

15 August 2019 | By Nic Losardo (Drug Target Review)

Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.

Single enzyme provides target for new sepsis drugs

14 August 2019 | By Rachael Harper (Drug Target Review)

Researchers have discovered that removing the enzyme, PHLPP1, improves outcomes in a mouse model of sepsis so could be a potential drug target.

Blood-brain barrier role in Alzheimer’s patients revealed by tissue model

13 August 2019 | By Rachael Harper (Drug Target Review)

A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.

Parkinson’s disease symptoms “improved” by oestrogen

13 August 2019 | By Rachael Harper (Drug Target Review)

New research into sex-based differences of Parkinson's disease could lead to new treatments.

Direct toxic action of beta-amyloid in Alzheimer’s patients identified

12 August 2019 | By Rachael Harper (Drug Target Review)

The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.

Therapeutic target for Kennedy’s disease and prostate cancer proposed

9 August 2019 | By Rachael Harper (Drug Target Review)

A chaperone protein has been identified as a possible therapeutic target for the treatment of Kennedy's disease and prostate cancer.